These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9616735)

  • 21. Growth of recombinant fibroblasts in alginate microcapsules.
    Chang PL; Hortelano G; Awrey DE; Tse M
    Biotechnol Bioeng; 1994 Apr; 43(10):925-33. PubMed ID: 18615439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microencapsulation of normal and transfected L929 fibroblasts in a HEMA-MMA copolymer.
    Lahooti S; Sefton MV
    Tissue Eng; 2000 Apr; 6(2):139-49. PubMed ID: 10941209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic delivery of recombinant proteins by genetically modified myoblasts.
    Barr E; Leiden JM
    Science; 1991 Dec; 254(5037):1507-9. PubMed ID: 1962212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of small alginate microcapsules for recombinant gene product delivery to the rodent brain.
    Ross CJ; Chang PL
    J Biomater Sci Polym Ed; 2002; 13(8):953-62. PubMed ID: 12463513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological properties of photocrosslinked alginate microcapsules.
    Shen F; Li AA; Cornelius RM; Cirone P; Childs RF; Brash JL; Chang PL
    J Biomed Mater Res B Appl Biomater; 2005 Nov; 75(2):425-34. PubMed ID: 16035031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanically enhanced microcapsules for cellular gene therapy.
    Shen F; Mazumder MA; Burke NA; Stöver HD; Potter MA
    J Biomed Mater Res B Appl Biomater; 2009 Jul; 90(1):350-61. PubMed ID: 19090494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice.
    Wen J; Xu N; Li A; Bourgeois J; Ofosu FA; Hortelano G
    J Gene Med; 2007 Nov; 9(11):1002-10. PubMed ID: 17868187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agarose enhances the viability of intraperitoneally implanted microencapsulated L929 fibroblasts.
    Lahooti S; Sefton MV
    Cell Transplant; 2000; 9(6):785-96. PubMed ID: 11202565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Encapsulation for somatic gene therapy.
    Chang PL
    Ann N Y Acad Sci; 1999 Jun; 875():146-58. PubMed ID: 10415564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immuno-isolation in cancer gene therapy.
    Cirone P; Potter M; Hirte H; Chang P
    Curr Gene Ther; 2006 Apr; 6(2):181-91. PubMed ID: 16611041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-vivo delivery of therapeutic proteins by genetically-modified cells: comparison of organoids and human serum albumin alginate-coated beads.
    Shinya E; Dervillez X; Edwards-Lévy F; Duret V; Brisson E; Ylisastigui L; Lévy MC; Cohen JH; Klatzmann D
    Biomed Pharmacother; 1999 Dec; 53(10):471-83. PubMed ID: 10665341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microencapsulation and transplantation of genetically engineered cells: a new approach to somatic gene therapy.
    Basic D; Vacek I; Sun AM
    Artif Cells Blood Substit Immobil Biotechnol; 1996 May; 24(3):219-55. PubMed ID: 8773741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel approach to tumor suppression with microencapsulated recombinant cells.
    Cirone P; Bourgeois JM; Austin RC; Chang PL
    Hum Gene Ther; 2002 Jul; 13(10):1157-66. PubMed ID: 12133269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delivery of recombinant product from subcutaneous implants of encapsulated recombinant cells in canines.
    Stockley TL; Robinson KE; Delaney K; Ofosu FA; Chang PL
    J Lab Clin Med; 2000 Jun; 135(6):484-92. PubMed ID: 10850648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained and therapeutic delivery of factor IX in nude haemophilia B mice by encapsulated C2C12 myoblasts: concurrent tumourigenesis.
    Hortelano G; Wang L; Xu N; Ofosu FA
    Haemophilia; 2001 Mar; 7(2):207-14. PubMed ID: 11260281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospects for delivery of recombinant angiostatin by cell-encapsulation therapy.
    Visted T; Furmanek T; Sakariassen P; Foegler WB; Sim K; Westphal H; Bjerkvig R; Lund-Johansen M
    Hum Gene Ther; 2003 Oct; 14(15):1429-40. PubMed ID: 14577923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascularization and improved in vivo survival of VEGF-secreting cells microencapsulated in HEMA-MMA.
    Vallbacka JJ; Sefton MV
    Tissue Eng; 2007 Sep; 13(9):2259-69. PubMed ID: 17523877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro characterization and in vivo functionality of erythropoietin-secreting cells immobilized in alginate-poly-L-lysine-alginate microcapsules.
    Murua A; de Castro M; Orive G; Hernandez RM; Pedraz JL
    Biomacromolecules; 2007 Nov; 8(11):3302-7. PubMed ID: 17941669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of viability and proliferation of alginate-poly-L-lysine-alginate encapsulated myoblasts using flow cytometry.
    Thakur A; Sengupta R; Matsui H; Lillicrap D; Jones K; Hortelano G
    J Biomed Mater Res B Appl Biomater; 2010 Aug; 94(2):296-304. PubMed ID: 20586078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue-engineered human bioartificial muscles expressing a foreign recombinant protein for gene therapy.
    Powell C; Shansky J; Del Tatto M; Forman DE; Hennessey J; Sullivan K; Zielinski BA; Vandenburgh HH
    Hum Gene Ther; 1999 Mar; 10(4):565-77. PubMed ID: 10094200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.